Home » Tenders » Europe » Italy » Multicenter Phase Ii, Open-Label Study To Evaluate The Efficacy, Safety, Pharmacokinetics... Tender

Multicenter Phase Ii, Open-Label Study To Evaluate The Efficacy, Safety, Pharmacokinetics... Tender

Download Documents

IRCCS Istituto Neurologico Carlo Besta has floated a tender for Multicenter Phase Ii, Open-Label Study To Evaluate The Efficacy, Safety, Pharmacokinetics And Pharmacodynamics Of Satralizumab In Pediatric Patients With Duchenne Muscular Dystrophy (Shield Dmd). The project location is Italy and the tender is closing on 09 Aug 2024. The tender notice number is , while the TOT Ref Number is 105094178. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.

Procurement Summary

Country : Italy

Summary : Multicenter Phase Ii, Open-Label Study To Evaluate The Efficacy, Safety, Pharmacokinetics And Pharmacodynamics Of Satralizumab In Pediatric Patients With Duchenne Muscular Dystrophy (Shield Dmd)

Deadline : 09 Aug 2024

Other Information

Notice Type : Tender

TOT Ref.No.: 105094178

Document Ref. No. :

Competition : ICB

Financier : Self Financed

Purchaser Ownership : Public

Tender Value : Refer Document

Purchaser's Detail

Name :Login to see tender_details

Address : Login to see tender_details

Email : Login to see tender_details

Tender Details

Tender Are Invited Multicenter Phase Ii, Open-Label Study To Evaluate The Efficacy, Safety, Pharmacokinetics And Pharmacodynamics Of Satralizumab In Pediatric Patients With Duchenne Muscular Dystrophy (Shield Dmd)

Documents

Tender Notice

Browse More

All Tenders From Italy

All Tenders From Europe

Want To Bid in This Tender?

Get Local Agent Support in Italy and 60 More Countries.

View All The Services

View Tenders By

Publish Tenders

Superior Approach, High ROI

Instantneous Global Reach